Ignite Creation Date:
2025-12-24 @ 8:02 PM
Ignite Modification Date:
2026-03-07 @ 9:27 PM
Study NCT ID:
NCT03213704
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-03
First Post:
2017-07-10
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-08-23
Start Date Type:
ACTUAL
Primary Completion Date:
2024-09-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-10-08
Completion Date Type:
ESTIMATED
First Submit Date:
2017-07-10
First Submit QC Date:
None
Study First Post Date:
2017-07-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-09-29
Results First Submit QC Date:
None
Results First Post Date:
2025-10-16
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-14
Last Update Post Date:
2025-12-03
Last Update Post Date Type:
ESTIMATED